Topical application of senolytic ABT-263 accelerates wound healing in aged mice
Researchers at Boston University found that applying the senolytic drug ABT-263 directly to the skin of aged mice reduced the accumulation of senescent cells and significantly improved wound healing rates. The study suggests that clearing damaged cells before an injury occurs may prime aging skin for a more robust repair response, potentially offering a future strategy for managing slow-healing wounds in older adults.